These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 30586704

  • 21. Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).
    Sen H, Lam MK, Löwik MM, Danse PW, Jessurun GA, van Houwelingen KG, Anthonio RL, Tjon Joe Gin RM, Hautvast RW, Louwerenburg JH, de Man FH, Stoel MG, van der Heijden LC, Linssen GC, IJzerman MJ, Tandjung K, Doggen CJ, von Birgelen C.
    JACC Cardiovasc Interv; 2015 Jun; 8(7):889-99. PubMed ID: 26003019
    [Abstract] [Full Text] [Related]

  • 22. Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial.
    Kim SH, Kang SH, Lee JM, Chung WY, Park JJ, Yoon CH, Suh JW, Cho YS, Doh JH, Cho JM, Bae JW, Youn TJ, Chae IH.
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):1399-1406. PubMed ID: 31859438
    [Abstract] [Full Text] [Related]

  • 23. Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
    Colleran R, Kufner S, Harada Y, Giacoppo D, Cassese S, Repp J, Wiebe J, Lohaus R, Lahmann A, Schneider S, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA, Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Investigators.
    Catheter Cardiovasc Interv; 2017 Feb 15; 89(3):367-374. PubMed ID: 27377301
    [Abstract] [Full Text] [Related]

  • 24. Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients.
    Youn YJ, Lee JW, Ahn SG, Lee SH, Yoon J, Park KS, Lee JB, Yoo SY, Lim DS, Cho JH, Choi CU, Jeong MH, Han KR, Cha KS, Lee SY, Choi HH, Choi JW, Hyon MS, Kim MH.
    Circ Cardiovasc Interv; 2020 Mar 15; 13(3):e008525. PubMed ID: 32160779
    [Abstract] [Full Text] [Related]

  • 25. The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent.
    Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH, Coleman PS, Stoler RC, Papadakos S, Cutlip DE, Mauri L, Kandzari DE, ENDEAVOR IV Investigators.
    JACC Cardiovasc Interv; 2013 Apr 15; 6(4):325-33. PubMed ID: 23523453
    [Abstract] [Full Text] [Related]

  • 26. Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    van Hemert ND, Rozemeijer R, Voskuil M, Stein M, Frambach P, Rittersma SZ, Kraaijeveld AO, Leenders GEH, van der Harst P, Agostoni P, Stella PR, ReCre8 Study Investigators.
    Catheter Cardiovasc Interv; 2022 Feb 15; 99(2):366-372. PubMed ID: 33811730
    [Abstract] [Full Text] [Related]

  • 27. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 28. One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis.
    Wang H, Xie X, Zu Q, Lu M, Chen R, Yang Z, Gao Y.
    Cardiovasc Diabetol; 2022 Oct 28; 21(1):220. PubMed ID: 36307791
    [Abstract] [Full Text] [Related]

  • 29. Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial.
    Lee JM, Park SD, Lim SY, Doh JH, Cho JM, Kim KS, Bae JW, Chung WY, Youn TJ.
    Trials; 2013 Nov 20; 14():398. PubMed ID: 24257456
    [Abstract] [Full Text] [Related]

  • 30. Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial.
    Han JK, Yang S, Hwang D, Park SH, Kang J, Yang HM, Park KW, Kang HJ, Koo BK, Cho JM, Cho J, Bang DW, Lee JH, Lee HC, Kim KJ, Chun WJ, Seo WW, Park WJ, Park SM, Kim JW, Kim HS.
    Circ Cardiovasc Interv; 2024 Jul 20; 17(7):e013585. PubMed ID: 38786579
    [Abstract] [Full Text] [Related]

  • 31. Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial.
    Iñiguez A, Chevalier B, Richardt G, Neylon A, Jiménez VA, Kornowski R, Carrie D, Moreno R, Barbato E, Serra-Peñaranda A, Guiducci V, Valdés-Chávarri M, Yajima J, Wijns W, Saito S, CENTURY II study investigators.
    Catheter Cardiovasc Interv; 2020 Feb 20; 95(2):175-184. PubMed ID: 31033154
    [Abstract] [Full Text] [Related]

  • 32. Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial.
    Xu B, Yang Y, Yuan Z, Du Z, Wong SC, Généreux P, Lu S, RESOLUTE China RCT Investigators.
    JACC Cardiovasc Interv; 2013 Jul 20; 6(7):664-70. PubMed ID: 23523240
    [Abstract] [Full Text] [Related]

  • 33. A randomized comparison of novel biodegradable polymer- and durable polymer-coated cobalt-chromium sirolimus-eluting stents.
    Han Y, Xu B, Jing Q, Lu S, Yang L, Xu K, Li Y, Li J, Guan C, Kirtane AJ, Yang Y, I-LOVE-IT 2 Investigators.
    JACC Cardiovasc Interv; 2014 Dec 20; 7(12):1352-60. PubMed ID: 25440887
    [Abstract] [Full Text] [Related]

  • 34. 2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.
    Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W, TARGET AC Investigators.
    JACC Cardiovasc Interv; 2019 Sep 09; 12(17):1679-1687. PubMed ID: 31129092
    [Abstract] [Full Text] [Related]

  • 35. Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).
    Maeng M, Christiansen EH, Raungaard B, Kahlert J, Terkelsen CJ, Kristensen SD, Carstensen S, Aarøe J, Jensen SE, Villadsen AB, Lassen JF, Thim T, Eftekhari A, Veien KT, Hansen KN, Junker A, Bøtker HE, Jensen LO, SORT OUT VIII Investigators.
    JACC Cardiovasc Interv; 2019 Apr 08; 12(7):624-633. PubMed ID: 30947936
    [Abstract] [Full Text] [Related]

  • 36. Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.
    Postma W, Fabris E, Van der Ent M, Hermanides R, Buszman P, Von Birgelen C C, Cook S, Wedel H, De Luca G, Delewi R, Zijlstra F, Kedhi E.
    Catheter Cardiovasc Interv; 2020 Mar 01; 95(4):706-710. PubMed ID: 31268629
    [Abstract] [Full Text] [Related]

  • 37. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW, Lee JM, Kang SH, Ahn HS, Kang HJ, Koo BK, Rhew JY, Hwang SH, Lee SY, Kang TS, Kwak CH, Hong BK, Yu CW, Seong IW, Ahn T, Lee HC, Lim SW, Kim HS.
    JACC Cardiovasc Interv; 2014 May 01; 7(5):471-81. PubMed ID: 24852802
    [Abstract] [Full Text] [Related]

  • 38. Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry.
    Rozemeijer R, Benedetto D, Kraaijeveld AO, Voskuil M, Stein M, Timmers L, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR.
    Cardiovasc Revasc Med; 2018 Jul 01; 19(5 Pt A):521-525. PubMed ID: 29137966
    [Abstract] [Full Text] [Related]

  • 39. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
    Chandrasekhar J, Kok MM, Kalkman DN, Aquino MB, Zocca P, Woudstra P, Beijk MA, Kerkmeijer LS, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Pocock S, von Birgelen C, Mehran R, de Winter RJ, COMBO Collaborators and BIO-RESORT Investigators.
    JACC Cardiovasc Interv; 2020 Apr 13; 13(7):820-830. PubMed ID: 32273094
    [Abstract] [Full Text] [Related]

  • 40. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
    Li XT, Sun H, Zhang DP, Xu L, Ni ZH, Xia K, Liu Y, Chi YH, He JF, Li WM, Wang HS, Wang LF, Yang XC.
    Coron Artery Dis; 2014 Aug 13; 25(5):405-11. PubMed ID: 24584031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.